|
|
|
|||||
Archive:
| |||||
There are three drugs in the same class already on the market, Remicade, Humira and Enbrel. But Dr Day said most people needed a variety of drugs to combat the illness. (Sydney Morning Herald -- Australia)
J&J 3Q profit falls on charge Oct 18, 2007
1 billion at J&J's biggest division, prescription drugs, led by Risperdal and other anti-psychotic drugs; epilepsy treatment Topamax; and Remicade for arthritis and other immune disorders. In medical devices and diagnostics, sales rose 6 percent to $5. (Yahoo News -- Pharmaceutical Industry News)
Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients Oct 16, 2007
PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of colectomy surgeries for patients with moderately to severely active ulcerative colitis (UC). According to a primary analysis of long-term extension data from the Active Ulcerative Colitis 1 and 2 trials (ACT trials), there is a 41 percent reduction in the incidence of colectomy, the surgical removal of... (EurekAlert!)
Civil case against Pinegar nears end Oct 15, 2007
In April Pinegar, a former family practice physician in Alva, pleaded guilty during his criminal trial in federal court to charges of overbilling Medicare for two prescription drugs Procrit and Remicade. He was sentenced to 33 months in prison and pay restitution of $543,566. (Alva Review Courier, OK)
Antibodies forecast to stay fastest-growing drugs Oct 14, 2007
The market is dominated by a handful of success stories with Roche (ROG.VX) and Genentech's (DNA.N) Avastin, Herceptin and Rituxan, Abbott's (ABT.N) Humira and Johnson on's (JNJ.N) Remicade accounting for 80 percent of sales in 2006. The commercial dominance of these products is expected to continue, with the same five drugs forecast to account for 70 percent of 2012 antibody revenues. (Yahoo News -- Pharmaceutical Industry News)
Abbott drug maintains psoriasis relief in trial Oct 2, 2007
Two leading approved psoriasis drugs, Amgen Inc's Enbrel and Johnson & Johnson's Remicade, work instead by blocking another inflammation-causing protein called tumor necrosis factor (TNF). Abbott's own Humira, a blockbuster treatment for rheumatoid arthritis that is awaiting U.S. approval for psoriasis, also blocks TNF.. (San Diego Union-Tribune -- Business)
For these startups, patients are a virtue Oct 1, 2007
I hope the Remicade continues to work for you. Hang in there, okay. (San Francisco Chronicle -- Business)
Analysis of FDA data shows near-tripling of reported deaths and drug reactions in 7 years Sep 14, 2007
Drugs frequently linked with serious nonfatal complications included insulin, the arthritis drugs Vioxx and Remicade, and the antidepressant Paxil. The report adds to recent criticism of FDA oversight on drug safety, including its handling of serious problems connected with Vioxx, which was removed from the market in 2004. (North County Times)
Many Arthritis Patients Not Happy with Prednisone Sep 11, 2007
Dr. Goekoop-Ruiterman of Leiden University Medical Center and colleagues evaluated survey responses from 440 adults who had taken part in a clinical trial of treatments for RA that included methotrexate and prednisone -- two older RA drugs -- and infliximab (Remicade) -- a newer anti-RA drug. The patients had had therapy for an average of 2. (MEDLINEplus)
OUR OPINION: State board makes right call on Senate proposal Sep 4, 2007
Zclaacls wrote on Sep 2, 2007 11:40 PM:" From this crippling se remifentanil suicide and reminyl profits. Distributive justice to good remodulin were allowed mostly used renacidin tracers. Ferrets are injuries to renagel establish mandatory rena-vite procedure. Citizen does diarrhea was on brain renografin nature of renova collection. Liability laws great risk were mildly aspects of transport. Principles and first in renzapride syndrome in potassium levels outbreak. Kong could awards against for... (Demopolis Times, AL)
Drug switch may benefit arthritis patients Sep 1, 2007
The most common initial drug was infliximab (Remicade), and second-line agents were usually adalimumab (Humira) or etanercept (Enbrel). To evaluate what impact this might have, the researchers examined a national biological treatment database with 1,021 patients and identified 235 who switched to a second TNF-alpha blocker after the initial drug failed. (Scientific American)
New Arthritis Drugs: Skin Cancer Risk Sep 1, 2007
Study: Slightly Higher Skin Cancer Risk With Remicade and Enbrel By WebMD Medical News Reviewed by. Aug. 29, 2007 -- Rheumatoid arthritis patients on Remicade or Enbrel have a small but higher risk of skin cancer, a new study confirms ... Three of these drugs are approved in the U.S.: Remicade, Enbrel, and Humira. (WebMD)
Rheumatoid Arthritis Drugs Linked to Slight Skin Cancer Risk Aug 31, 2007
WEDNESDAY, Aug. 29 (HealthDay News) -- People taking rheumatoid arthritis drugs such as etanercept (Enbrel) or infliximab (Remicade) may be at a slightly increased risk for skin cancer, researchers report. However, the risk is probably not significant enough to outweigh the benefits of these drugs, the researchers said. (MEDLINEplus)
PDL Lands in a Hazard Aug 30, 2007
Before being shelved, Nuvion had the potential to be the only biologic besides Johnson and Johnson's (NYSE: JNJ) Remicade to help treat refractory ulcerative colitis. advertisement. (MSNBC -- Business)
New drugs spark hope for help for Crohn's disease Aug 23, 2007
Two of these drugs, Remicade and Humira, are antibodies that bind to TNF, interfering with its function and helping to prevent symptoms. Remicade and Humira are the first drugs to make a noticeable dent in the rates of hospitalization and surgery for Crohn's patients, says Dr. Stephen Hanauer, chief of gastroenterology at the University of Chicago ... With Remicade, his condition is more manageable than it has been in years. (The Daily Reflector)
Resident says disease made him feel ashamed’ Aug 23, 2007
His current medicines, Enbrel and Remicade, have kept him in shorts and short sleeve shirts for more than four years. Three weeks ago, one our kids got sick, Westfall said. (McKinney Courier-Gazette, TX)
EvoGenix shareholders approve merger Aug 10, 2007
The merged group noted they would have in excess of $167 million in cash to advance product development and would receive on-going revenue streams from Abbott and Johnson on in relation to blockbuster anti-inflammatory antibody drugs Humira and Remicade. Peptech CEO Dr John Chiplin will be the CEO of the merged company, while a restructured board will oversee the next stage of its development. (egoli.com.au)
Merck, Schering-Plough post profit jumps Jul 24, 2007
They include Remicade, for arthritis and other inflammatory immune disorders, up 28 percent to $394 million, and Nasonex, for allergies, up 22 percent to $295 million. The company's consumer health care segment posted $394 million in sales, up 13 percent, while sales in the animal health segment increased 10 percent to $264 million. (Yahoo News -- Pharmaceutical Industry News)
Schering-Plough 2Q Profit Soars Jul 23, 2007
The top-selling products and their results: Remicade, for arthritis and other inflammatory immune disorders, up 28 percent to $394 million; Nasonex, for allergies, up 22 percent to $295 million; Pegintron, hepatitis C, up 3 percent to $234 million; Clarinex, an antihistamine, up 11 percent to $250 million; and Temodar, for brain tumors, grew 26 percent to $216 million. The company's consumer health care segment posted $394 million in sales in the second quarter, up 13 percent compared with a... (Newsday -- Business)
New Crohn's Disease Drug Shows Promise Jul 20, 2007 Weak J&J forecast sours strong quarterly results Jul 18, 2007 Johnson & Johnsons earnings rise Jul 18, 2007 Johnson & Johnson reports 9% profit rise Jul 18, 2007 Johnson & Johnson's Q2 profit jumps 9 percent, but sales of stents and once-popular drug drop Jul 18, 2007 Arthritis Drug May Treat Stubborn Psoriasis Jul 11, 2007 Flexible Arthritis Treatments Can Ease Pain Jun 27, 2007 AstraZeneca, Bristol-Myers Overcharged on Some Medicare Drugs, Judge Rules Jun 22, 2007 Remicade data in ankylosing spondylitis show improvement in spinal mobility and spinal inflammation Jun 15, 2007 NHS to review arthritis drugs use Jun 13, 2007 New use approved in Europe for Centocor drug Jun 8, 2007 Priced out of pain relief May 8, 2007 Peptech skips to next plan - biotech merger May 8, 2007 Peptech to merge with EvoGenix May 7, 2007 Researchers identify new therapy for patients with Crohn's disease May 2, 2007 Spending on biotech drug prescriptions rising Apr 26, 2007 Pinegar sentenced to 33 months in prison Apr 23, 2007 Former Ada doctor sentenced to prison for Medicare fraud Apr 21, 2007 Calls for govt to subsidise Crohn drug Apr 20, 2007 Dow extends record high by 5 points Apr 20, 2007 Massachusetts General Hospital reaps $284m drug sale windfall Apr 19, 2007 Stocks Head Toward Lower Opening Apr 19, 2007 Schering-Plough profit jumps 55% Apr 19, 2007 Schering-Plough posts 55 percent rise in 1st-quarter earnings Apr 19, 2007 J&J Net Income Falls 22 Percent After Acquisitions (Update5) Apr 18, 2007 Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals Apr 11, 2007 Budget threatens medical miracle Apr 4, 2007 European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R) Mar 26, 2007 New hope for those suffering from Crohn–s Mar 20, 2007 FDA CAPSULES Mar 6, 2007 New Crohn's disease treatment Humira promises to reduce symptoms Mar 1, 2007 Abbott gets FDA approval to sell arthritis drug for Crohn's disease Feb 28, 2007 Abbott gets OK to promote Humira for Crohn's Feb 28, 2007 FDA approves new treatment for crohn's disease Feb 28, 2007 Genentech loses patent dispute with MedImmune Feb 22, 2007 Patent ruling could cost Genentech $100 million Feb 22, 2007 A 2001 Genentech biotechnology patent is revoked Feb 22, 2007 Genentech loses ruling on patent Feb 22, 2007 Genentech drug patent is rejected Feb 22, 2007 Drug maker produces documentary on chronic illness Feb 21, 2007 2 new treatments for Crohn's due soon Feb 19, 2007 Psoriasis Group Responds to 'Stunning' Results of CNTO 1275 Clinical Trial Feb 8, 2007 J&J psoriasis drug posts mixed results in trial Feb 8, 2007 Sleep apnea leaves peoplefeeling foggy next morning Feb 7, 2007 Sleep apnea; Rheumatoid arthritis Feb 7, 2007 New psoriasis treatmentsmay help when others fail Feb 6, 2007 Mitsubishi to acquire Tanabe in $4.3 billion takeover Feb 5, 2007 Firms tout study results at dermatology conference Feb 4, 2007 2nd trial shows Abbott's Humira eases psoriasis Feb 3, 2007 Biologic Drug Humira Psoriasis Trial Provides Encouraging Results Feb 3, 2007 New analyses reinforce efficacy of Remicade in treatment of severe psoriasis Feb 3, 2007 Remicade therapy shown to improve productivity in patients treated for chronic plaque psoriasis Feb 3, 2007 Nasonex Unclogs Schering-Plough Profit Jan 30, 2007 Schering-Plough profit rises on cholesterol drugs Jan 30, 2007 Tyson sees profit, but feed costs rising Jan 30, 2007 S&P Keeps Strong Buy on Citigroup Jan 30, 2007 New treatment is a godsendfor ulcerative colitis patient Jan 25, 2007 Earnings: Yahoo, Sun Microsystems, AMD, More... Jan 24, 2007 Sluggishness of psoriasis drug sales raises questions on prices Jan 24, 2007 New drugs relieve, may cure, rheumatoid arthritis Jan 21, 2007 Everyday tasks a burden with rheumatoid arthritis Jan 21, 2007 Biologic Drugs Comparable for Rheumatoid Disease Jan 20, 2007 Asia: Merger talks propel shares Jan 19, 2007
The introduction of the first anti-TNF drug, infliximab (Remicade), revolutionized the treatment of Crohn's disease, wrote Dr. James Lewis, an associate professor of medicine and epidemiology at the University of Pennsylvania, in a commentary accompanying the two studies. Another drug, adalimumab (Humira), is now available. (MEDLINEplus)
Experimental drug effective for Crohn's disease Jul 19, 2007
Like drugs such as infliximab (Remicade) and adalimumab (Humira), certolizumab works by blocking a chemical called tumor necrosis factor. However, certolizumab is constructed a bit differently and is less likely to destroy certain immune cells. (Scientific American)
1 billion, fueled by sales of epilepsy drug Topamax, arthritis treatment Remicade and Risperdal. But U.S. sales of Procrit fell 14 percent to 449 million, following widely publicized reports of deaths among patients taking higher doses of such drugs that boost numbers of red blood cells. (Yahoo News -- Pharmaceutical Industry News)
Top-selling prescription drugs included Topamax for epilepsy, Concerta for attention deficit hyperactivity disorder, Risperdal and other anti-psychotic drugs, and Remicade for arthritis and other inflammatory immune disorders. We can offset certain challenges in parts of our business with performance in others, Chief Financial Officer Dominic Caruso told analysts during a conference call, touting the value of our broad-based business. (MSNBC -- Business)
Top-selling prescription drugs included anemia treatment Procrit, Topamax for epilepsy and Remicade for arthritis and other inflammatory immune disorders. "We continue to grow earnings while successfully integrating acquisitions and continuing to invest in promising new growth opportunities," said William Weldon, chairman and chief executive officer. (USA Today -- Money)
Top-selling prescription drugs included Topamax for epilepsy, Concerta for attention deficit hyperactivity disorder, Risperdal and other anti-psychotic drugs, and Remicade for arthritis and other inflammatory immune disorders. For the first six months of the year, net income totaled $5. (San Diego Union-Tribune -- Business)
Patients with severe psoriasis previously treated with Enbrel (also known as etanercept) may respond to Remicade (also known as infliximab), a study published this month suggests. Remicade, which is given by intravenous infusion and is used to treat arthritis, has shown promising results for the treatment of severe psoriasis and may be considered in patients who are unresponsive to other drugs, Drs ... In the Journal of the American Academy of Dermatology, the researchers report their experience... (Newsmax)
said that common treatments include drugs such as Celebrex, Enbrel, methotrexate and Remicade. Others try over-the-counter pain relievers such as ibuprofen or naproxen. (Click2Houston, TX)
Johnson & Johnson's Remicade, used to treat Crohn's disease and rheumatoid arthritis, was listed in the independent publication Red Book in 2001 at $665. 65 a dose, court records show, while the New Brunswick, New Jersey-based company charged doctors about a third of that, according to Prescription Access Litigation, a Boston-based consumer advocacy group. (Bloomberg -- UK)
BARCELONA, Spain, 15 June 2007 Data presented today at the European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology showed that patients with ankylosing spondylitis (AS) who received REMICADE (infliximab) over two years experienced significant improvement in spinal mobility. In addition, REMICADE-treated patients showed sustained reductions in spinal inflammation through two years as detected by magnetic resonance imaging (MRI) ... The recommended dose of REMICADE... (EurekAlert!)
The National Institute for Health and Clinical Excellence (NICE) will look again at Humira, Enbrel and Remicade. Last year it ruled if a patient did not respond to one of the drugs - from a class known as anti-TNF medicines - they should not get another. (BBC News)
The European Commission on Thursday expanded the label for Remicade, a drug co-marketed by and , to include its use a treatment of severe, active Crohn's disease in children ages 6 to 17. The approval allows for Remicade, a biologic therapy, to be used as a treatment for pediatric Crohn's disease patients who have not responded to conventional therapy ... Remicade is also approved in the European Union for rheumatoid arthritis and psoriatic arthritis. (Philadelphia Business Journal, PA)
" Health insurers routinely require patients to pay a portion of their medication costs. But the stakes are becoming a lot higher as an increasing number of high-priced biologic drugs come to market. Such drugs are based on substances produced by living cells. Rheumatology patients such as Wild have been hit especially hard because the field has benefited from the introduction of a number of newer biologic drugs, including Remicade, Enbrel and Humira. Biologic drugs are also used to treat... (San Francisco Chronicle -- Business)
Two years ago Peptech was poised to merge with the Brisbane biotech Agenix but Agenix pulled out, citing a dispute between Peptech and Johnson & Johnson unit Centocor over the anti-inflammatory drug Remicade. Peptech derives royalties from its intellectual property in two drugs, Remicade - produced by Johnson & Johnson - and Humira, produced by Abbott. (Sydney Morning Herald -- Business)
In addition the combined company receives on-going revenue streams from Abbott and Johnson on in relation to blockbuster antibody, anti-TNF drugs Humira and Remicade. Peptechs own next generation anti-TNF drug will enter the clinic this month. (egoli.com.au)
-- A study led by Mayo Clinic found that adalimumab (HUMIRA)) is an effective treatment for adults with Crohns disease who do not respond to infliximab (REMICADE) therapy ... Remicade (infliximab) is a product of Centocor, Inc.. (EurekAlert!)
7 billion for Johnson & Johnson's Remicade for arthritis, and $3. 7 billion for Celgene Corp.'s cancer drug Thalomid. (Scientific American)
Through his plea, Pinegar has admitted that he intentionally submitted false claims to Medicare for two prescription medications: Procrit and Remicade. Procrit is administered by injection and is primarily used to treat anemia in patients with serious kidney disease as well as anemia caused by certain medications, such as some types of chemotherapy and medications to treat HIV. Remicade is administered by intravenous infusions and is primarily used to treat patients with moderate to severe Crohn... (Alva Review Courier, OK)
Federal prosecutors say Doctor Gregory Glase Pinegar admitted sending false bills to Medicare from January 2000 through May 2005 for the prescription drugs Procrit and Remicade. Procrit is used to treat anemia and Remicade is used to treat Crohn's disease and rheumatoid arthritis. (KFOR Oklahoma City, OK)
The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the expensive drug Infliximab, also known as Remicade, be listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of severe Crohn's disease. Patients pay between $3,600 and $4,000 for each treatment, which are generally required every eight weeks and must be injected by a doctor. (Sydney Morning Herald -- Australia)
Schering-Plough said its first-quarter profit soared 55%, boosted by strong demand for its Remicade drug and other products; its results beat Wall Street's forecast. In other economic data Thursday, the Labor Department said weekly applications for unemployment benefits slipped by 4,000 to 339,000 after hitting a two-month high a week earlier. (USA Today -- Money)
Enbrel, which has also been approved by the Food and Drug Administration to treat psoriasis, faces competition from Humira and Remicade. "We certainly believe in the product, but there are market forces that you need to consider," said Frances Toneguzzo , director of technology licensing at Mass. (Boston Globe)
Schering-Plough Corp. said its first-quarter profit soared 55 percent, boosted by strong demand for its Remicade drug and other products; its results beat Wall Street's forecast. Late Wednesday, Kraft Foods Inc., the world's second-largest food and beverage maker, said its first-quarter profit fell 30 percent, but excluding certain items the report was better than analysts predicted. (ABC 7 News, DC)
KENILWORTH, N.J. Schering-Plough Corp. said Thursday its first-quarter profit rose 55 per cent to easily beat Wall Street expectations, helped by strong demand for its Remicade drug and other products ... Sales of Remicade increased 34 per cent to $373-million, driven by continued market growth and expanded indications for its use ... Remicade is a treatment for immune-mediated inflammatory disorders that Schering-Plough markets in countries outside the United States for rheumatoid arthritis,... (Globe and Mail -- Business)
April 19, 2007, 8:00 AM EDT NEWARK, N.J. -- Schering-Plough Corp. said Thursday its first-quarter profit rose 55 percent to easily beat Wall Street expectations, helped by strong demand for its Remicade drug and other products ... Sales of Remicade increased 34 percent to $373 million, driven by continued market growth and expanded indications for its use. (Newsday -- State)
Centocor, which sells the competing Remicade arthritis medicine, and the university say Humira infringes on their patent covering antibodies against tumor necrosis factor, or TNF, which is linked to inflammation. To contact the reporter on this story: Lisa Rapaport in New York at. (Bloomberg)
This encapsulated antisense approach has demonstrated targeted delivery to specific cell types with a rapid onset of action and greater in vivo efficacy than the anti-inflammatory blockbuster Remicade. Elias Papatheodorou, CEO of Novosom AG, commented: "We are very happy to have reached an agreement with the industry leader in oligonucleotide therapeutics for Novosom's first proprietary therapeutic program. We feel that of the current oligo-based technologies, Isis' antisense 2' MOE chemistry... (Canada Newswire)
Nino s NIH treatment includes methotrexate, as well as Remicade, approved by the Federal Drug Administration for treatment of arthritis and Crohn s Disease but not for PFS.. Therein lies a big problem. (Carlisle Sentinel, PA)
and KENILWORTH, N.J., March 26 /PRNewswire-FirstCall/ -- Centocor, Inc. and Schering-Plough Corporation (NYSE: ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending the approval of REMICADE(R) (infliximab) for the treatment of severe, active Crohn's disease (CD) in pediatric patients aged 6 to 17 years, who have not responded to conventional therapy including a corticosteroid, an... (PR Newswire)
Until now the most beneficial treatment for Crohn's has been the drug Remicade. However, according to Throckmorton, some patients cannot tolerate Remicade, and some become resistant to it over time ... According to Dr. William Caccese, a gastroenterologist in Plainview, a major advantage of Humira over Remicade is that Humira requires only one injection every other week, while Remicade must be given intravenously during several hours in a doctor's office. (Newsday -- Health)
The drug is targeted toward patients "who have had an inadequate response to conventional therapy, and in those patients who did not benefit from treatment, or who were intolerant to previous treatment with Remicade (infliximab) therapy," said Dr. Douglas Throckmorton, deputy director of FDA's Center for Drug Evaluation and Research. www. (Newsday -- Health)
It also induced and maintained a clinical remission of Crohn's disease in patients who did not respond well to conventional therapy or were unable to tolerate the drug Remicade (Johnson & Johnson). Humira carries a "black-box" warning, the strongest type of FDA label warning, indicating that it's use has been associated with serious, sometimes fatal, infections, including cases of tuberculosis, opportunistic infections, and sepsis. (News-Medical.net)
Humira competes with Johnson & Johnson's Remicade, approved in 1998 for treating Crohn's. Unlike Remicade, which requires a doctor's office or infusion center visit for treatment, Humira is self-injected twice a month with a pen-like device. (Boston Globe)
Dr. Douglas Throckmorton, deputy director of FDA's Center for Drug Evaluation and Research, said Humira "has been shown to reduce signs and symptoms, and to induce and maintain clinical remission of Crohn's disease" in patients who did not respond well to conventional therapy or could not tolerate Johnson on's drug Remicade. Advertisement. (Crain's Chicago Business)
"Humira has been shown to reduce signs and symptoms, and to induce and maintain clinical remission of Crohn's disease in patients who have had an inadequate response to conventional therapy, and in those patients who did not benefit from treatment, or who were intolerant to previous treatment with Remicade (infliximab) therapy," said Dr. Douglas Throckmorton, Deputy Director of FDA's Center for Drug Evaluation and Research. "Today's approval provides patients and their health care providers with... (SpiritIndia)
They are MedImmune's Synagis for treating a respiratory disease; Erbitux, a cancer treatment made by ImClone Systems of New York; Remicade, an inflammatory disorder treatment made by Johnson & Johnson of New Jersey; and the arthritis treatment Humira, made by Abbott Laboratories of Illinois. Bill Bertrand, MedImmune's general counsel, said executives at his company ``were very happy'' with last week's ruling by the U.S. Patent and Trademark Office. (San Jose Mercury News)
In addition to MedImmune, the companies that contribute most royalties under the patent are Abbot, for its drug Humira; Centocor, for Remicade; and Imclone, for its cancer drug Erbitux, Teeter said. Despite the patent office ruling, Genentech shares gained 80 cents Wednesday to close at $87. (San Francisco Chronicle -- Business)
A Genentech spokesman said the biggest royalties come from Humira by Abbott, Remicade by Johnson & Johnson, Synagis by MedImmune and Erbitux by ImClone. An analyst at Sanford Bernstein, Geoffrey Porges, wrote in a note on Wednesday that the impact of the decision "is greater for the companies paying royalties on Cabilly than it is for Genentech.". (International Herald Tribune -- Business)
Licensed products that use the Cabilly patent include MedImmune's Synagis, a treatment for respiratory illness in infants; Erbitux, the cancer drug made by ImClone; and the autoimmune medicines Remicade by Johnson & Johnson and Humira by Abbott, both of which treat rheumatoid arthritis. In a rejection notice posted Feb. 16 on the patent office's website, the patent examiner said the invention is just an obvious variation of technology already covered by earlier patents. (Boston Globe -- Business)
The bulk of the Cabilly royalties come from MedImmune's Synagis, which treats respiratory ailments in infants, as well as the rheumatoid arthritis drugs Humira (made by Abbott Laboratories) and Remicade (made by Centacor Inc.), and the cancer drug Erbitux (made by ImClone). Federal regulators re-examined the patent after two official requests to do so, one on behalf of MedImmune and another from an unnamed party. (Sunspot.net -- Business)
The 58-minute film, which was to have its premiere Wednesday in New York, is an unusual form of soft-pedal marketing of a blockbuster drug, Remicade. The documentary never specifically mentions Remicade, or the product's maker, Centocor, a unit of Johnson & Johnson ... Instead, it focuses on several of the autoimmune diseases Remicade is approved to treat: rheumatoid arthritis, psoriasis and Crohn's disease. (International Herald Tribune -- Technology)
Dr. Adam S. Cheifetz, who treats patients with Crohn's, said only two-thirds respond to Remicade , the first biologic treatment approved by the Food and Drug Administration for adults with moderate to severe Crohn's. Even those who do respond can build resistance to Remicade over time ... "The biggest difference this is going to make is for those people who had been doing well on Remicade, and then lost their response. That was a problem group of patients," said Cheifetz, clinical director of... (Boston Globe)
CNTO 1275 is produced by Centocor, which also makes Remicade, approved for the treatment of psoriasis, psoriatic arthritis and other diseases. Centocor's press release reports that the company is moving forward to Phase Three testing of CNTO 1275. (PR Newswire)
Many of the most widely used current drugs, including J&J's Remicade, work instead by blocking an inflammatory protein called tumor necrosis factor TNF ... "Based upon these Phase II results, the efficacy of CNTO 1275 seems very comparable to what we've seen with Remicade" in separate trials of that older J&J treatment, said Michael Parks, a spokesman for J&J's Centocor division. (ABC News -- Wire)
Remicade is another biological drug that's given by intravenous injection. I'm certain your doctor knows about these medicines. (The Standard-Times, MA)
" Sleep apnea is periods during sleep when a person's breathing stops for 10 seconds or more. Eventually breathing starts again, but the continual repetitions of apnea fragment sleep and make people groggy the following day. They also aggravate many medical conditions, like heart failure and high blood pressure.Sleep apnea comes in two varieties. The more common one is obstructive sleep apnea. Lax tissue and flabby muscles in the back of the throat obstruct the flow of air to the lungs. In this... (Herald-Tribune)
Two other injected biologicals are Amevive and Remicade, administered by a doctor or nurse. Sunlight can help some psoriasis patients, as can artificial ultraviolet light. (The Standard-Times, MA)
Tanabe has sold Johnson on's Remicade drug since 2002. The medicine for autoimmune diseases, including arthritis, was Tanabe's best-selling drug in the nine-month period, with sales of 15. (International Herald Tribune -- Business Asia)
Centocor released the results of a clinical study Friday that, according to the company, reinforces the case that its flagship product Remicade is an effective psoriasis treatment. The study found that three out of four patients taking Remicade for severe psoriasis showed a 75 percent improvement after 10 weeks on the drug ... The study also found patients receiving Remicade experienced significant improvements in nail psoriasis, an often difficult-to-treat and painful manifestation that occurs... (Philadelphia Business Journal, PA)
Amgen Inc.'s rheumatoid arthritis drug Enbrel and Johnson on's rheumatoid arthritis drug Remicade have already received U.S. marketing approval for treating psoriasis. The disease affects about 125 million people worldwide. (Crain's Chicago Business)
Two other biologics used to treat rheumatoid arthritis, Amgen Inc.'s Enbrel and Centocor's Remicade, have already received FDA approval for treating psoriasis. In the new Humira study involving 1,200 patients with moderate to severe chronic plaque psoriasis, patients were randomized to receive either Humira every other week beginning at week one or a placebo. (Biologic Drug Report)
Data show patients with severe psoriasis affecting the nails experienced significant improvements with Remicade therapy. WASHINGTON, DC, February 2, 2007 -- Findings from an integrated analysis of data from three pivotal, randomized, placebo-controlled trials showed that at week 10 more than three-quarters of patients with severe psoriasis receiving REMICADE (infliximab) 3 mg/kg or 5 mg/kg achieved a 75 percent improvement in the chronic, inflammatory skin disease as measured by the Psoriasis... (EurekAlert!)
WASHINGTON, D.C., February 2, 2007 -- Investigators reported today at the American Academy of Dermatology annual meeting that patients with moderate to severe plaque psoriasis receiving REMICADE (infliximab) induction and maintenance therapy experienced significant improvements in productivity at week 10, which were sustained through week 50. After 10 weeks, patients receiving REMICADE 3 mg/kg or 5 mg/kg achieved significant improvements in work and daily activities (2 ... "These findings show... (EurekAlert!)
NEW YORK (Dow Jones) -- Schering-Plough Corp. said on Monday that fourth-quarter profit jumped, helped by strength in its Remicade and Nasonex brands ... Sales of the company's rheumatoid arthritis drug Remicade, co-marketed by Johnson & Johnson, increased 34% to $337 million. (SmartMoney)
NEW YORK Schering-Plough Corp. said Monday that fourth-quarter profit rose 75 percent, helped by strong demand for its Remicade arthritis drug and Vytorin and Zetia cholesterol fighters ... Sales of Remicade, a treatment for rheumatoid arthritis that Schering-Plough sells overseas, soared 34 percent to $337 million, helped by recent approvals for new uses. (San Diego Union-Tribune -- Business)
Sales of anti-inflammatory drug Remicade, for disorders such as rheumatoid arthritis and ulcerative colitis, jumped 34 percent to $337 million, and allergy drug Nasonex revenues advanced 37 percent to $253 million. Mattel Inc., the world's largest toymaker, reported fourth-quarter net income of $286. (San Diego Union-Tribune -- Business)
However, sales growth of 14% exceeded our forecast, driven by strength in Remicade (+34%) and Nasonex (+37%). Equity income from the Vytorin/Zetia venture with Merck (; 4 STARS) climbed 50% to $403 million. (BusinessWeek)
He suggested a new drug called Remicade ... Remicade is a new medicine ... It's gratifying that Remicade has brought you good health, but not everyone can expect such a transformation. (The Standard-Times, MA)
Sales of arthritis drug Remicade grew 13 percent to $780 million, while those of attention deficit disorder treatment Concerta rose 24 percent to $257 million. But combined sales of anemia drugs Procrit and Eprex slipped 1 percent to $788 million, hurt by longer-acting rival Aranesp sold by Amgen Inc.. (Fox News)
A Johnson on drug, Remicade, already used for rheumatoid arthritis and Crohn's disease, won approval for psoriasis in September. Humira, from Abbott Laboratories, is approved for psoriatic arthritis and is now being tested for psoriasis itself. (International Herald Tribune -- Business)
Dona Whitaker of La Jolla receives an infusion of Remicade to treat her rheumatoid arthritis at the Encinitas office of Dr. Roy A. Kaplan ... They are Remicade, Enbrel, Humira, Orencia, Rituxan and drugs still in testing ... That grim picture started changing in 1998, when the first of these immune-modulating drugs, Remicade, was approved by the U.S. Food and Drug Administration. (North County Times)
In 2001 she was put on Remicade ... That's longer than her success with Remicade, but not as long yet as with Humira, a three-year period of relief. (North County Times)
NEW YORK (Reuters Health) - Humira (adalimumab), Remicade (infliximab), and Enbrel (etanercept) are useful rheumatoid arthritis treatments and have comparable effectiveness and safety, according to an analysis of combined data ... For example, Humira, Kineret and Enbrel can be injected by the patient, whereas Remicade requires an office visit every 4 to 8 weeks for injection ... Gartlehner concluded: "Given the similar effectiveness of Humira, Enbrel, and Remicade, decisions about the choice of... (MEDLINEplus)
Tanabe, which supplies Japan with the best-selling arthritis treatment in the world, Remicade, jumped 88 to 1,716. Mitsubishi Chemical rose 43 to 815. (International Herald Tribune -- Business Asia)
Back to FindHealthNews Home
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
Copyright SurfWax, Inc. 2006 |